{"id":24001,"date":"2026-04-23T15:25:23","date_gmt":"2026-04-23T19:25:23","guid":{"rendered":"https:\/\/www.ices.on.ca\/?post_type=journal_article&#038;p=24001"},"modified":"2026-05-14T15:36:48","modified_gmt":"2026-05-14T19:36:48","slug":"effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/","title":{"rendered":"Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis"},"content":{"rendered":"<p><strong>Background<\/strong> \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced guidance for changes to OAT delivery, including relaxed take-home dosing and expanded virtual care. We examined how the pandemic influenced OAT initiation trends.<\/p>\n<p><strong>Methods<\/strong> \u2014 We conducted a population-based, retrospective interrupted time series analysis using linked administrative health data from March 2018 to January 2022 in Ontario, Canada. OAT initiations were defined as new (no OAT prescribed in the preceding two years) prescriptions for methadone, buprenorphine\/naloxone, or slow-release oral morphine. Weekly initiation trends were compared before and during two pandemic periods defined by provincial emergency declarations. Analyses were stratified by medication type and sex.<\/p>\n<p><strong>Results<\/strong> \u2014 We identified 31,866 new OAT initiations. Immediately after the pandemic began, initiations declined significantly (-36.7\/week; 95% CI: -53.3 to -20.1), then gradually returned toward baseline. Overall initiation volumes during the pandemic were not clearly different from pre-pandemic levels, although estimates were imprecise. However, prescribing patterns shifted: we estimate that methadone initiations increased by 2321 (95% CI: 1600 to 3043), while buprenorphine\/naloxone initiations declined by 2009 (95% CI: \u22122783 to \u22121235) as a result of the pandemic. Sex-stratified trends were consistent with overall findings.<\/p>\n<p><strong>Conclusions<\/strong> \u2014 The pandemic led to a temporary drop in OAT initiations but no long-term decline. A shift toward methadone suggests changing preferences among prescribers and patients, potentially driven by updated guidance and rising drug toxicity. These findings support the need for flexible, low-barrier OAT delivery models that can adapt to public health emergencies and evolving unregulated drug supply risks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced guidance for changes to OAT delivery, including relaxed take-home dosing and expanded virtual care. We examined how the pandemic influenced OAT initiation trends. Methods \u2014 We conducted a population-based, retrospective interrupted time series analysis [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[34,56,35],"migration-helper-qa-sample-set":[],"class_list":["post-24001","journal_article","type-journal_article","status-publish","hentry","topic-mental-health-and-addictions","topic-pharmacoepidemiology-and-drug-safety","topic-public-health"],"acf":{"citation":"Young S, Raboud J, Dodd Z, Barnett-Tapia C, Gomes T, Fairbairn N, Bayoumi AM. <em>Int J Drug Policy<\/em>. 2026; 153: 105275. Epub 2026 Apr 23.","source_url":"https:\/\/doi.org\/10.1016\/j.drugpo.2026.105275","ices_scientist":[1252,1170],"site":[6733],"research_program":[6745],"news_release":"","journal_article":"","atlas":"","research_report":"","infographic":"","video":"","downloads":null,"links":null,"sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":"","previous_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis<\/title>\n<meta name=\"description\" content=\"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis\" \/>\n<meta property=\"og:description\" content=\"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-14T19:36:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\\\/\",\"name\":\"ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2026-04-23T19:25:23+00:00\",\"dateModified\":\"2026-05-14T19:36:48+00:00\",\"description\":\"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis","description":"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis","og_description":"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2026-05-14T19:36:48+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/","name":"ICES | Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2026-04-23T19:25:23+00:00","dateModified":"2026-05-14T19:36:48+00:00","description":"Background \u2014 Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/effect-of-the-covid-19-pandemic-on-initiations-of-opioid-agonist-therapy-in-ontario\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: a population-based interrupted time series analysis"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/24001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6745"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1170"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1252"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=24001"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=24001"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=24001"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=24001"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=24001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}